GGrantIndex
← Leaderboards

John D Clements

Tulane University Of Louisiana

$19,870,217
Attributed
$19,870,217
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $13.5M · FY200515
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$19,870,217 · 7

By mechanism

C06$13,533,254 · 1
R01$2,379,659 · 2
U01$2,297,246 · 1
R21$1,094,554 · 2
R56$565,504 · 1

Top collaborators

No co-investigators on record.

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Top investigators on “Yersinia Pestis

Research focus

Yersinia PestisImmunityImmunizationLaboratory MouseCessation Of LifeAnimalsProteinsChildLifeVaccinesBioterrorism /Chemical WarfareCommunicable DiseasesVaccine DeliveryAntigensPreventBacillus AnthracisMorbidity - Disease RateMortality Vital StatisticsCellsMucosal ImmunityTherapeutic VaccineImmunomodulatorsImmunologicsInfection

Grant awards (18)

Physiologic and immunologic consequences of exposure to ETEC enterotoxins$188,125
R21 · FY2015 · AI · contact PI
Physiologic and immunologic consequences of exposure to ETEC enterotoxins$225,750
R21 · FY2014 · AI · contact PI
Nanocarriers for Vaccine Delivery$565,504
R56 · FY2013 · AI · contact PI
Tulane_University_Interdisciplinary_Bioscience_Initiative$13,533,254
C06 · FY2010 · RR · contact PI
Nanocarriers for transcutaneous delivery of vaccines$500,712
R01 · FY2009 · EB · contact PI
Nanocarriers for transcutaneous delivery of vaccines$486,465
R01 · FY2008 · EB · contact PI
Nanocarriers for transcutaneous delivery of vaccines$492,665
R01 · FY2007 · EB · contact PI
Novel adjuvants for biodefense vaccines$267,814
U01 · FY2007 · AI · contact PI
Nanocarriers for transcutaneous delivery of vaccines$502,990
R01 · FY2006 · EB · contact PI
Novel adjuvants for biodefense vaccines$270,029
U01 · FY2006 · AI · contact PI
Combinatorial vaccines against anthrax and plague$70,179
R21 · FY2006 · AI · contact PI
Novel adjuvants for biodefense vaccines$270,779
U01 · FY2005 · AI
Novel adjuvants for biodefense vaccines$460,814
U01 · FY2004 · AI
Combinatorial vaccines against anthrax and plague$313,500
R21 · FY2004 · AI
Novel adjuvants for biodefense vaccines$1,027,810
U01 · FY2003 · AI
Combinatorial vaccines against anthrax and plague$297,000
R21 · FY2003 · AI
MECHANISM OF CHOLERA TOXIN AND E COLI LT ADJUVANTICITY$201,345
R01 · FY2001 · AI
MECHANISM OF CHOLERA TOXIN AND E COLI LT ADJUVANTICITY$195,482
R01 · FY2000 · AI